Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation and Employee Benefit Plans (Tables)

v3.7.0.1
Stock-Based Compensation and Employee Benefit Plans (Tables)
3 Months Ended
Mar. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock-Based Compensation
The Company recognizes stock-based compensation in the consolidated statements of income, based on the department to which the related employee reports, as follows:
 
Three Months Ended March 31,
 
2017
 
2016
 
(in thousands)
Cost of net revenue
$
59

 
$
43

Research and development
3,493

 
3,279

Selling, general and administrative
1,922

 
1,787

 
$
5,474

 
$
5,109

Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block]
 
Number of Shares
(in thousands)
 
Weighted-Average Grant-Date Fair Value per Share
Outstanding at December 31, 2016
3,670

 
$
14.67

Granted
549

 
26.66

Vested
(507
)
 
16.78

Canceled
(76
)
 
16.61

Outstanding at March 31, 2017
3,636

 
16.15

Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]
 
Three Months Ended
 
March 31, 2017
Weighted-average grant date fair value per share
$
6.20

Risk-free interest rate
0.60
%
Dividend yield
%
Expected life (in years)
0.50

Volatility
49.94
%
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]
A summary of the Company’s stock options activity is as follows:
 
Number of Options
(in thousands)
 
Weighted-Average Exercise Price
 
Weighted-Average Contractual Term (in years)
 
Aggregate Intrinsic Value (in thousands)
Outstanding at December 31, 2016
3,025

 
$
6.78

 
 
 
 
Granted(1)

 
N/A

 
 
 
 
Exercised
(90
)
 
3.96

 
 
 
 
Canceled(2)

 
N/A

 
 
 
 
Outstanding at March 31, 2017
2,935

 
$
6.87

 
2.53
 
$
62,160

Vested and expected to vest at March 31, 2017
2,931

 
$
6.87

 
2.53
 
$
62,091

Exercisable at March 31, 2017
2,693

 
$
6.77

 
2.43
 
$
57,331